Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Non-Current Debt (2021 - 2025)

Historic Non-Current Debt for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Q3 2025 value amounting to $107.5 million.

  • Arcutis Biotherapeutics' Non-Current Debt rose 228.65% to $107.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.5 million, marking a year-over-year increase of 228.65%. This contributed to the annual value of $107.2 million for FY2024, which is 4687.63% down from last year.
  • Arcutis Biotherapeutics' Non-Current Debt amounted to $107.5 million in Q3 2025, which was up 228.65% from $107.0 million recorded in Q2 2025.
  • Arcutis Biotherapeutics' Non-Current Debt's 5-year high stood at $203.8 million during Q2 2024, with a 5-year trough of $72.4 million in Q4 2021.
  • Its 5-year average for Non-Current Debt is $147.2 million, with a median of $152.2 million in 2022.
  • As far as peak fluctuations go, Arcutis Biotherapeutics' Non-Current Debt soared by 17335.04% in 2022, and later tumbled by 4765.74% in 2024.
  • Arcutis Biotherapeutics' Non-Current Debt (Quarter) stood at $72.4 million in 2021, then soared by 173.35% to $197.8 million in 2022, then grew by 2.04% to $201.8 million in 2023, then tumbled by 46.88% to $107.2 million in 2024, then increased by 0.28% to $107.5 million in 2025.
  • Its Non-Current Debt was $107.5 million in Q3 2025, compared to $107.0 million in Q2 2025 and $107.6 million in Q1 2025.